EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 41 / No 4 (Avril 2025) Med Sci (Paris), 41 4 (2025) 374-379 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 4, Avril 2025
Page(s) 374 - 379
Section Repères
DOI https://doi.org/10.1051/medsci/2025044
Published online 28 April 2025
  1. Silverstein J, Post AL, Chien AJ, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract 2020 ; 16 : 545–57. [CrossRef] [PubMed] [Google Scholar]
  2. Lishner M, Avivi I, Apperley JF, et al. Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting. J Clin Oncol 2016 ; 34 : 501–8. [CrossRef] [PubMed] [Google Scholar]
  3. Di Ciaccio PR, Mills G, Tang C, et al. Managing haematological malignancies in pregnant women. Lancet Haematol 2021 ; 8 : e623–4. [CrossRef] [PubMed] [Google Scholar]
  4. Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017 ; 17 : 469–82. [CrossRef] [PubMed] [Google Scholar]
  5. Pariente G, Leibson T, Carls A, et al. Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS Med 2016 ; 13 : e1002160. [CrossRef] [PubMed] [Google Scholar]
  6. Gerwen M van, Maggen C, Cardonick E, et al. Association of chemotherapy timing in pregnancy with congenital malformation. JAMA Netw Open 2021 ; 4 : e2113180. [CrossRef] [PubMed] [Google Scholar]
  7. Ancel P-Y, Goffinet F, EPIPAGE-2 Writing Group, et al. Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr 2015 ; 169 : 230–8. [CrossRef] [PubMed] [Google Scholar]
  8. Pierrat V, Marchand-Martin L, Marret S, et al. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study. BMJ 2021 ; 373 : n741. [CrossRef] [PubMed] [Google Scholar]
  9. Griffiths SK, Campbell JP. Placental structure, function and drug transfer. CCECCP 2015 ; 15 : 84–9. [Google Scholar]
  10. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 2022 ; 36 : 1703–19. [CrossRef] [PubMed] [Google Scholar]
  11. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 2022 ; 36 : 1720–48. [CrossRef] [PubMed] [Google Scholar]
  12. Le Guyader-Peyrou S, Defossez G, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Santé publique France ; 2 : 169. [Google Scholar]
  13. Tuppin P, Rudant J, Constantinou P, et al. Value of a national administrative database to guide public decisions: from the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France. Rev Epidemiol Sante Publique 2017 ; 65 Suppl 4 : S149–67. [CrossRef] [PubMed] [Google Scholar]
  14. Pinson P, Boussaid I, Decroocq J, et al. Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study. The Lancet Haematology 2024 ; 11 : e850–61. [CrossRef] [PubMed] [Google Scholar]
  15. Van Assche IA, Huis In ’t Veld EA, Van Calsteren K, et al. Cognitive and behavioral development of 9-year-old children after maternal cancer during pregnancy: a prospective multicenter cohort study. J Clin Oncol 2023 ; 41 : 1527–32. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.